Review



ficolin 2 ficolin b polyclonal antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Bioss ficolin 2 ficolin b polyclonal antibody
    Ficolin 2 Ficolin B Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ficolin 2 ficolin b polyclonal antibody/product/Bioss
    Average 92 stars, based on 3 article reviews
    ficolin 2 ficolin b polyclonal antibody - by Bioz Stars, 2026-03
    92/100 stars

    Images



    Similar Products

    ficolin 2 ficolin b polyclonal antibody  (Bioss)
    92
    Bioss ficolin 2 ficolin b polyclonal antibody
    Ficolin 2 Ficolin B Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ficolin 2 ficolin b polyclonal antibody/product/Bioss
    Average 92 stars, based on 1 article reviews
    ficolin 2 ficolin b polyclonal antibody - by Bioz Stars, 2026-03
    92/100 stars
    		  Buy from Supplier
    fcn1  (Sino Biological)
    91
    Sino Biological fcn1
    Fcn1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fcn1/product/Sino Biological
    Average 91 stars, based on 1 article reviews
    fcn1 - by Bioz Stars, 2026-03
    91/100 stars
    		  Buy from Supplier
    rabbit anti-ficolin 2 polyclonal antibody  (Huabio Inc)
    90
    Huabio Inc rabbit anti-ficolin 2 polyclonal antibody
    Rabbit Anti Ficolin 2 Polyclonal Antibody, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-ficolin 2 polyclonal antibody/product/Huabio Inc
    Average 90 stars, based on 1 article reviews
    rabbit anti-ficolin 2 polyclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    rabbit anti‐ficolin 2 polyclonal antibody  (Huabio Inc)
    90
    Huabio Inc rabbit anti‐ficolin 2 polyclonal antibody
    Rabbit Anti‐Ficolin 2 Polyclonal Antibody, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti‐ficolin 2 polyclonal antibody/product/Huabio Inc
    Average 90 stars, based on 1 article reviews
    rabbit anti‐ficolin 2 polyclonal antibody - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    rabbit ficolin  (Bioss)
    92
    Bioss rabbit ficolin
    Expression levels of 17 genes based on GEPIA2 (Gene Expression Profiling Interactive Analysis web server). (A) ANGPTL6 . (B) CFP . (C) CLEC1B . (D) CLEC4G . (E) CLEC4M . (F) COLEC10 . (G) CRHBP . (H) CXCL12 . (I) DNASE1L3 . (J) <t>FCN2</t> . (K) FCN3 . (L) GSTZ1 . (M) LCAT . (N) NAT2 . (O) OIT3 . (P) RSPO3 . (Q) VIPR1 . * p < 0.05. The y -axis represents the relative log2 expression value (TPM + 1).
    Rabbit Ficolin, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit ficolin/product/Bioss
    Average 92 stars, based on 1 article reviews
    rabbit ficolin - by Bioz Stars, 2026-03
    92/100 stars
    		  Buy from Supplier
    rabbit anti ficolin a polyclonal antibody  (Proteintech)
    93
    Proteintech rabbit anti ficolin a polyclonal antibody
    Expression levels of 17 genes based on GEPIA2 (Gene Expression Profiling Interactive Analysis web server). (A) ANGPTL6 . (B) CFP . (C) CLEC1B . (D) CLEC4G . (E) CLEC4M . (F) COLEC10 . (G) CRHBP . (H) CXCL12 . (I) DNASE1L3 . (J) <t>FCN2</t> . (K) FCN3 . (L) GSTZ1 . (M) LCAT . (N) NAT2 . (O) OIT3 . (P) RSPO3 . (Q) VIPR1 . * p < 0.05. The y -axis represents the relative log2 expression value (TPM + 1).
    Rabbit Anti Ficolin A Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti ficolin a polyclonal antibody/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti ficolin a polyclonal antibody - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression levels of 17 genes based on GEPIA2 (Gene Expression Profiling Interactive Analysis web server). (A) ANGPTL6 . (B) CFP . (C) CLEC1B . (D) CLEC4G . (E) CLEC4M . (F) COLEC10 . (G) CRHBP . (H) CXCL12 . (I) DNASE1L3 . (J) FCN2 . (K) FCN3 . (L) GSTZ1 . (M) LCAT . (N) NAT2 . (O) OIT3 . (P) RSPO3 . (Q) VIPR1 . * p < 0.05. The y -axis represents the relative log2 expression value (TPM + 1).

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Expression levels of 17 genes based on GEPIA2 (Gene Expression Profiling Interactive Analysis web server). (A) ANGPTL6 . (B) CFP . (C) CLEC1B . (D) CLEC4G . (E) CLEC4M . (F) COLEC10 . (G) CRHBP . (H) CXCL12 . (I) DNASE1L3 . (J) FCN2 . (K) FCN3 . (L) GSTZ1 . (M) LCAT . (N) NAT2 . (O) OIT3 . (P) RSPO3 . (Q) VIPR1 . * p < 0.05. The y -axis represents the relative log2 expression value (TPM + 1).

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques: Expressing

    Survival analysis of 17 genes. (A) ANGPTL6 . (B) CFP . (C) CLEC1B . (D) CLEC4G . (E) CLEC4M . (F) COLEC10 . (G) CRHBP . (H) CXCL12 . (I) DNASE1L3 . (J) FCN2 . (K) FCN3 . (L) GSTZ1 . (M) LCAT . (N) NAT2 . (O) OIT3 . (P) RSPO3 . (Q) VIPR1 . (R) Constructed protein–protein interaction (PPI) network of the important differentially expressed genes (DEGs) using STRING. (S) Use of the Cytoscape plug-in MCODE to select the most important module from the PPI network.

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Survival analysis of 17 genes. (A) ANGPTL6 . (B) CFP . (C) CLEC1B . (D) CLEC4G . (E) CLEC4M . (F) COLEC10 . (G) CRHBP . (H) CXCL12 . (I) DNASE1L3 . (J) FCN2 . (K) FCN3 . (L) GSTZ1 . (M) LCAT . (N) NAT2 . (O) OIT3 . (P) RSPO3 . (Q) VIPR1 . (R) Constructed protein–protein interaction (PPI) network of the important differentially expressed genes (DEGs) using STRING. (S) Use of the Cytoscape plug-in MCODE to select the most important module from the PPI network.

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques: Construct

    Pan-tissue expression of FCN2 . (A) Pan-cancer expression of FCN2 in the Oncomine database. (B) Expression of FCN2 in normal tissues in the BioGPS database. (C) Pan-cancer expression of FCN2 in the UCSC (University of California, Santa Cruz) database. (D) Log2 transformation of the pan-cancer expression value of FCN2 in the UCSC database. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns: not statistically significant.

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Pan-tissue expression of FCN2 . (A) Pan-cancer expression of FCN2 in the Oncomine database. (B) Expression of FCN2 in normal tissues in the BioGPS database. (C) Pan-cancer expression of FCN2 in the UCSC (University of California, Santa Cruz) database. (D) Log2 transformation of the pan-cancer expression value of FCN2 in the UCSC database. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns: not statistically significant.

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques: Expressing, Transformation Assay

    Transcription levels of FCN2 in liver cancer and normal tissues. (A–C) Expression differences of the FCN2 gene between liver cancer tissues and normal tissues in the Oncomine database. (D) FCN2 mRNA expression in liver cancer tissue and normal tissue based on the GEPIA2 database (TCGA tumors vs . TCGA normal). (E, F) FCN2 protein expression in hepatocellular carcinoma in the UALCAN database. (G) Part of the results of the immunohistochemistry experiments. (H) Average optical density of liver cancer tissues and adjacent tissues from 30 liver cancer patients. TCGA , The Cancer Genome Atlas. * p < 0.05, *** p < 0.001.

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Transcription levels of FCN2 in liver cancer and normal tissues. (A–C) Expression differences of the FCN2 gene between liver cancer tissues and normal tissues in the Oncomine database. (D) FCN2 mRNA expression in liver cancer tissue and normal tissue based on the GEPIA2 database (TCGA tumors vs . TCGA normal). (E, F) FCN2 protein expression in hepatocellular carcinoma in the UALCAN database. (G) Part of the results of the immunohistochemistry experiments. (H) Average optical density of liver cancer tissues and adjacent tissues from 30 liver cancer patients. TCGA , The Cancer Genome Atlas. * p < 0.05, *** p < 0.001.

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques: Expressing, Immunohistochemistry

    Different expression levels of FCN2 in liver hepatocellular carcinoma (LIHC) based on The Cancer Genome Atlas (TCGA) analyzed using R. (A) Pathologic stages. (B) Histological grade. (C) Fibrosis Ishak scale scores. (D) Race. (E) Normal tissue and liver cancer. (F) Adjacent hepatic tissue inflammation. (G) Age (H) . BMI. (I) Alpha-fetoprotein (AFP). (J) Vascular invasion. (K) Gender. * p < 0.05, ** p < 0.01, *** p < 0.001. ns: not statistically significant.

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Different expression levels of FCN2 in liver hepatocellular carcinoma (LIHC) based on The Cancer Genome Atlas (TCGA) analyzed using R. (A) Pathologic stages. (B) Histological grade. (C) Fibrosis Ishak scale scores. (D) Race. (E) Normal tissue and liver cancer. (F) Adjacent hepatic tissue inflammation. (G) Age (H) . BMI. (I) Alpha-fetoprotein (AFP). (J) Vascular invasion. (K) Gender. * p < 0.05, ** p < 0.01, *** p < 0.001. ns: not statistically significant.

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques: Expressing

    Prognostic value of FCN2 in liver cancer. (A–D) Overall survival (OS) (A) , relapse-free survival (RFS) (B) , disease-specific survival (DSS) (C) , and patient-free survival/progression-free survival (PFS) (D) . (E) Nomogram predicting the 1-, 3-, and 5-year OS probability. (F) C-index of the prognostic model nomogram for predicting the 1-, 3-, and 5-year OS probability in hepatocellular carcinoma (HCC) patients. (G) Prediction of the 1-, 3-, and 5-year OS probability using nomogram calibration plots.

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Prognostic value of FCN2 in liver cancer. (A–D) Overall survival (OS) (A) , relapse-free survival (RFS) (B) , disease-specific survival (DSS) (C) , and patient-free survival/progression-free survival (PFS) (D) . (E) Nomogram predicting the 1-, 3-, and 5-year OS probability. (F) C-index of the prognostic model nomogram for predicting the 1-, 3-, and 5-year OS probability in hepatocellular carcinoma (HCC) patients. (G) Prediction of the 1-, 3-, and 5-year OS probability using nomogram calibration plots.

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques:

    Protein–protein interaction network analysis and enrichment analysis. (A, B) Gene network diagram of interaction with FCN2 created using the STRING database. (C–G) Diagrams of the analyses of the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) pathways.

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Protein–protein interaction network analysis and enrichment analysis. (A, B) Gene network diagram of interaction with FCN2 created using the STRING database. (C–G) Diagrams of the analyses of the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) pathways.

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques:

    Correlation of FCN2 expression with immune characteristics. (A) Differential distribution of the immune cells in patients with high and low FCN2 expressions. (B–G) Correlation between the expression level of FCN2 and immune infiltration in hepatocellular carcinoma: (B) Neutrophils, (C) Eosinophils, (D) NK cells, (E) Tcm, (F) DC, (G) Th2 cells. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, no significance.

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Correlation of FCN2 expression with immune characteristics. (A) Differential distribution of the immune cells in patients with high and low FCN2 expressions. (B–G) Correlation between the expression level of FCN2 and immune infiltration in hepatocellular carcinoma: (B) Neutrophils, (C) Eosinophils, (D) NK cells, (E) Tcm, (F) DC, (G) Th2 cells. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, no significance.

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques: Expressing

    Correlation analysis between FCN2 and the biomarkers of immune cells in hepatocellular carcinoma (HCC) determined using the GEPIA database (Spearman’s correlation coefficient).

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Correlation analysis between FCN2 and the biomarkers of immune cells in hepatocellular carcinoma (HCC) determined using the GEPIA database (Spearman’s correlation coefficient).

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques:

    Immunomodulators, chemokines, and receptors associated with FCN2 . (A) Distribution of the FCN2 immunological scores in tumor and normal tissues.The ordinate reflects the distribution of the immunological scores in distinct groups, whereas the abscissa indicates the immune cell types. The Wilcoxon test was used to compare statistical differences between the two groups, and the Kruskal–Wallis test was used to determine the significance of the differences between three groups. ( a ) Heatmap of the immune cell scores. Different hues represent the varied expression distributions in different samples. Asterisks indicate significance levels at * p < 0.05, ** p < 0.01, and *** p < 0.001. ( b ) Percentages of tumor-infiltrating immune cells in each sample. Different colors depict the different types of immunological cells. The abscissa denotes the sample, whereas the ordinate denotes the percentage of immune cells in a single sample. (H) Immunomodulators, chemokines, and receptors associated with FCN2 in liver hepatocellular carcinoma (LIHC). (B) CCL14. (C) CCL16. (D) CCL23. (E) TNFSF4. (F) CD276. (G) TNFRSF4. (H) KDR. **** p < 0.0001.

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Immunomodulators, chemokines, and receptors associated with FCN2 . (A) Distribution of the FCN2 immunological scores in tumor and normal tissues.The ordinate reflects the distribution of the immunological scores in distinct groups, whereas the abscissa indicates the immune cell types. The Wilcoxon test was used to compare statistical differences between the two groups, and the Kruskal–Wallis test was used to determine the significance of the differences between three groups. ( a ) Heatmap of the immune cell scores. Different hues represent the varied expression distributions in different samples. Asterisks indicate significance levels at * p < 0.05, ** p < 0.01, and *** p < 0.001. ( b ) Percentages of tumor-infiltrating immune cells in each sample. Different colors depict the different types of immunological cells. The abscissa denotes the sample, whereas the ordinate denotes the percentage of immune cells in a single sample. (H) Immunomodulators, chemokines, and receptors associated with FCN2 in liver hepatocellular carcinoma (LIHC). (B) CCL14. (C) CCL16. (D) CCL23. (E) TNFSF4. (F) CD276. (G) TNFRSF4. (H) KDR. **** p < 0.0001.

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques: Expressing

    Immunohistochemical comparison of FCN2 and the molecules with strong correlations [based on the Human Protein Atlas (HPA)].

    Journal: Frontiers in Oncology

    Article Title: Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer

    doi: 10.3389/fonc.2022.987481

    Figure Lengend Snippet: Immunohistochemical comparison of FCN2 and the molecules with strong correlations [based on the Human Protein Atlas (HPA)].

    Article Snippet: The samples were paraffin-fixed, cut into serial sections, and incubated with rabbit ficolin-2/ficolin-B polyclonal antibody (bs-13162R; Bioss, Woburn, MA, USA) at 4°C overnight.

    Techniques: Immunohistochemical staining